Loading...
Tafenoquine: A 2018 Novel FDA-Approved Prodrug for the Radical Cure of Plasmodium vivax Malaria and Prophylaxis of Malaria
Tafenoquine (an 8-aminoquinoline) was approved by the Food and Drug Administration (FDA) in 2018 for the radical cure of Plasmodium vivax malaria and preventive action against malaria. Despite the fact that the mechanism of action of the drug remains unclear, all studies indicated that a metabolite...
Na minha lista:
| Udgivet i: | Pharmaceuticals (Basel) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6789594/ https://ncbi.nlm.nih.gov/pubmed/31366060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph12030115 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|